We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$98.6B
AUM Growth
+$9.82B
(+11%)
Cap. Flow
+$3.18B
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
34.51%
Holding
3,532
New
899
Increased
935
Reduced
953
Closed
698
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.93B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Cencora
COR
|
+$492M |
| 4 |
Netflix
NFLX
|
+$452M |
| 5 |
Bank of America
BAC
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$636M |
| 2 |
Eli Lilly
LLY
|
+$572M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$502M |
| 4 |
Advanced Micro Devices
AMD
|
+$395M |
| 5 |
CRH
CRH
|
+$379M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.19% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 9.35% |
| 4 | Financials | 8.34% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Compass
COMP
$8.27B
| $14.1M | 0.01% |
1,762,022
-711,633
| -29% | -$5.76M |
|
777
NOV
NOV
$7.45B
| $14.1M | 0.01% |
+1,065,178
| New | +$13.8M |
|
778
Travere Therapeutics
TVTX
$5.33B
| $14.1M | 0.01% |
590,051
-152,674
| -21% | -$2.87M |
|
779
McCormick & Company Non-Voting
MKC
$13.4B
| $14M | 0.01% |
+209,450
| New | +$14.7M |
|
780
Akamai
AKAM
$16.8B
| $14M | 0.01% |
184,551
+138,512
| +301% | +$10.7M |
|
781
PUT
Salesforce
CRM
$134B
| $13.9M | 0.01% |
58,600
+51,000
| +671% | +$12.9M |
|
782
PACS Group
PACS
$7.42B
| $13.9M | 0.01% |
1,010,906
+785,537
| +349% | +$9.22M |
|
|
BLTE
783
Belite Bio
BLTE
$6.15B
| $13.9M | 0.01% |
187,500
+178,014
| +1,877% | +$11.7M |
|
784
Casey's General Stores
CASY
$31.9B
| $13.7M | 0.01% |
24,177
-21,104
| -47% | -$11M |
|
785
Neurocrine Biosciences
NBIX
$17.7B
| $13.7M | 0.01% |
97,289
+55,640
| +134% | +$7.54M |
|
786
PUT
Cheniere Energy
LNG
$56.5B
| $13.6M | 0.01% |
+58,000
| New | +$13.6M |
|
787
Appian
APPN
$1.74B
| $13.6M | 0.01% |
445,576
-163,778
| -27% | -$4.92M |
|
788
Procept Biorobotics
PRCT
$950M
| $13.6M | 0.01% |
381,534
+377,387
| +9,100% | +$17.2M |
|
789
PUT
Mercado Libre
MELI
$91.3B
| $13.6M | 0.01% |
+5,800
| New | +$13.9M |
|
790
iShare MSCI Eurozone ETF
EZU
$9.41B
| $13.5M | 0.01% |
+217,536
| New | +$13.1M |
|
|
OPRA
791
Opera Ltd
OPRA
$1.65B
| $13.5M | 0.01% |
651,965
-187,522
| -22% | -$3.35M |
|
792
United Natural Foods
UNFI
$3.01B
| $13.5M | 0.01% |
357,603
-430,177
| -55% | -$11.8M |
|
|
AL
793
DELISTED
Air Lease Corp
AL
| $13.4M | 0.01% |
210,227
+185,235
| +741% | +$11.1M |
|
794
NovoCure
NVCR
$2.04B
| $13.4M | 0.01% |
1,034,978
-379,621
| -27% | -$5.07M |
|
795
CALL
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
| $13.4M | 0.01% |
120,500
+120,400
| +120,400% | +$13.2M |
|
796
AngloGold Ashanti
AU
$40.3B
| $13.2M | 0.01% |
188,302
-1,755,388
| -90% | -$98.2M |
|
797
Ralph Lauren
RL
$22.2B
| $13.2M | 0.01% |
42,105
+38,776
| +1,165% | +$11.6M |
|
798
Freshworks
FRSH
$2.84B
| $13.1M | 0.01% |
1,113,493
+1,094,493
| +5,760% | +$14.7M |
|
799
SL Green Realty
SLG
$3.88B
| $13.1M | 0.01% |
218,634
-51,481
| -19% | -$3.05M |
|
800
Celsius Holdings
CELH
$6.93B
| $13.1M | 0.01% |
227,079
-1,057,537
| -82% | -$55.3M |
|
Similar funds
Marshall Wace's Q3 2025 Portfolio in Review
As of Q3 2025, Marshall Wace held 3,532 positions worth $98.6B, up 11% from $88.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $3.18B of net new capital in Q3 2025, opening 899 new positions and adding to 935 existing holdings. Its largest new stake was Texas Instruments: 1,537,539 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $636M trimmed.
- Marshall Wace's largest Q3 2025 buy was Texas Instruments: 1,537,539 shares worth $282M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2025, an estimated $3.93B increase.
- Marshall Wace's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $636M.
- Marshall Wace fully exited AT&T in Q3 2025, selling an estimated $235M.
- Marshall Wace's ten largest holdings make up 35% of its $98.6B portfolio in Q3 2025.
- Marshall Wace opened 899 new positions and closed 698 in Q3 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $98.6B.
Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.